{"name":"Insud Pharma","slug":"insud-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"T2,T3,T1","genericName":"T2,T3,T1","slug":"t2-t3-t1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"T2,T3,T1","genericName":"T2,T3,T1","slug":"t2-t3-t1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPM08yS0VDbHM2bXZOVlNHRUE2bi1GYUcwNTBOZld6SHpqeGpXb0dfSFJJRmM4ZEVsVEstc2Y5NlZWNGlNajdueDdwcU1JMlVBbWdsY2NCa0I2NWh2R1dVWWJSTWxSd1djVmpSelQ1SHIxcGZfVktpZnp0WXZzVEl1VVNDZHNjaWMxY3BiLW85UnVKM0VwdFVJTTdLRF91VnNOVU9VckNycmZYeDFwZGNDQmdzTDVncVhySzc1RE1JR3NrXzNvbG9mNjhMYm50UUU?oc=5","date":"2024-11-22","type":"pipeline","source":"Femtech Insider","summary":"Insud Pharma Receives $2.7M Gates Foundation Grant to Develop Sublingual Oxytocin for Postpartum Hemorrhage - Femtech Insider","headline":"Insud Pharma Receives $2.7M Gates Foundation Grant to Develop Sublingual Oxytocin for Postpartum Hemorrhage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNSWstLTVMYzlkR2VQbDFnOHBXMDNtZ3B2dDBQaFJpZXpQYy1oclR5blBvM1BSU2VTNjk4d2RZWGZ6OGZhdmFVQjlRZlFJekIycldGdnJ4RFN5MnJfelpzMWtnblJ2MGpfa2hBdEJNVENjZWVxck1EMWhNX2NYOFkxNUhMN3NSWWllWkU0bU9VRnk2bF9NbTJGOUduSll5NzcwQlc2REhXTEd6WVY3UDRFb09GeW1CSW5ibTMzZm4xZHlydHoyR2kwM3NnTWhGRGlmTVFUTFVYTl9hZw?oc=5","date":"2024-11-21","type":"pipeline","source":"BioSpace","summary":"New Alliance for the Development of a Sublingual Oxytocin Formulation to Prevent Postpartum Hemorrhage - BioSpace","headline":"New Alliance for the Development of a Sublingual Oxytocin Formulation to Prevent Postpartum Hemorrhage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQd2RuckFiVGdCSm1OV21MMzR0NkFzSW82YUswby13MHdYZ2hxRjRPZE5tcDRqaFBJcU53ZmdqRzlRaG1UOVFpdzB0ek5sZGpobXFSNVZpOTNiOHhRV0RMRDVZUEppMGpYdjZLLTQxcUJ4c0wydEt4WUU2bGtPbkFuZm9PZVMzY0hZZXpJdWFFTdIBlAFBVV95cUxPbmxpb1hUOXZVSXRDS0pKV3dXQmtsSnUteUlveXIxWUpoWGFvTENYU1dKZkJXMVowX3IxaXRwU2hLNXFDNDBDckJYQ2ljWFZ6TDV0bWFQcHdXbTBYbW5nWEk2N3E5ZU9TTFJuLUlzbEx4dnRycTJFekNpX3lPdF8wMldvdmhaOWFQbTZjNWNWWHRYT09W?oc=5","date":"2024-08-27","type":"pipeline","source":"Express Pharma","summary":"Insud Pharma completes acquisition of Agile Therapeutics - Express Pharma","headline":"Insud Pharma completes acquisition of Agile Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdWswZGUwa1prclpCQUFwRS1xRE1PVHByMkZ1NEFHakU4WmlfazdZaFFCX3JEeFNFUV8xdlF4amJFUTQ3NzF0UjAzTGlJNXBJellIRWhzMUlzVG0zakFIMDhBcnVUVkV6V3R0b183bk5QRXN2b01HQ1Vubm1waHhLaEZuc1JXWXV4Q3lnSDlUV0U1Y1hLbkx5YTNWUm1QNGxJemdya253aWFwVVY0YThaSDZnX0VGWjAzZGVjdWNXbEZBcy1YMDhub3ZQLXFJcDN1cm9tZEVtbw?oc=5","date":"2024-06-26","type":"deal","source":"roi-nj.com","summary":"Princeton women's health care company, Agile Therapeutics, to be acquired by Insud Pharma for $45M - roi-nj.com","headline":"Princeton women's health care company, Agile Therapeutics, to be acquired by Insud Pharma for $45M - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOVkx2dUN0VU0yeGhER1JDYlZrdjVnblZRM041Y2xyUTE2X1diOTEwaHpkUHBzbzlpdDBBMXYwY05RZGgxNHhUS3dTTjJjNXRUZ1JNeXE4YjRkUHF2R1JGTUpyYlI1bTQ2WEpCdlBKYXhEZTFCSTZ4c1F0U0REM3pqYTNRdVJtOE0zUUZILU9memlSU3BTQUhrZlowQk9rVFV0d2gwN093UkFVMnVUNWx4QzFxYnJfWkZMWjh5YmRIbEZPQWEyM1Z2Zkt0Z3FOQmZkVjhQbXZJYlFHbUp2YWZHUXJoeTNYZzN1LWdzdFN0dw?oc=5","date":"2024-06-26","type":"deal","source":"globenewswire.com","summary":"Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L. - globenewswire.com","headline":"Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPbUtYQm1ia2VRTTdJZ1R5SEtRVWJDYUJVU1l3Uy1ldG1LZlRTN2R6VFJIdzF0MXVQMWpXajZYNUJUdE16VHh5cE1KN25GRjZERFlsTWV1VUQxYlhYTEZnaHlMYTJYUlR0Tl92bjBabWNBRnpreHNUZzB4bzh6UFp3aDkzaVZWVm9sU0E?oc=5","date":"2024-03-20","type":"deal","source":"Drug Store News","summary":"Insud Pharma acquires Viatris' women's healthcare business - Drug Store News","headline":"Insud Pharma acquires Viatris' women's healthcare business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNSDVKblB1R0FDbUtqdE5wRURJbFhsZ0h5bTZzMFVjLWVvb2NZS01qRXo5NVp3d202cE1vd1A1S3Z4TzluS25wb3Q4UFJqNjhJUDgwRVlkRkJScTRYTjFJMldiTElYUTUwaTNick5yVlBVM3RwejBPaUdReHFUaDFtbTJDTUV0VEViOGxwMDhwc3FGcGJGeVlLUFJBbG8?oc=5","date":"2023-10-02","type":"pipeline","source":"fiercepharma.com","summary":"In selling 3 businesses, Viatris bids adieu to 10 manufacturing plants, 6,000 employees - fiercepharma.com","headline":"In selling 3 businesses, Viatris bids adieu to 10 manufacturing plants, 6,000 employees","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-09-17","type":"pipeline","source":"Medical Dialogues","summary":"Insud Pharma inaugrates Oligonucleotides Centre in India - Medical Dialogues","headline":"Insud Pharma inaugrates Oligonucleotides Centre in India","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-09-14","type":"pipeline","source":"The Times of India","summary":"Insud Pharma opens development & manufacturing centre for novel SMA oligonucleotide in Hyderabad - The Times of India","headline":"Insud Pharma opens development & manufacturing centre for novel SMA oligonucleotide in Hyderabad","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOQjRvRlVDTlJ1VGc0eVJQS0tDOVlMWmVJalBxM0s2aHk5SS1XaE1ZZmRRd2xoc1JUd1N6X0Mtc1VfZ3pqSXJsMzhPZmY4V1RJZ0R1cnJCLUNGRkRMUWp6X3cweHQxNUVhSnZkNHEySTgwNHNid1FKOFN3RzdMWG83WlAwSnd4ME9jRE5ucGZaWWRUamY1UENBTWJHWURxdVZISUVUcFVvaDByeDVoRDd3dEhMcE1QYUV6RGhsdzBsWlFxQmpOc3dPMnpfU3M5am5JUl8xWTJlUk5qZkpwazd3RUo1cmlWcFV2NkxhdlREY2FmNGVrdlRfb3VraGtCWEE?oc=5","date":"2022-11-23","type":"patent","source":"hsfkramer.com","summary":"SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING PATENTS - hsfkramer.com","headline":"SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZ0pmaG5Zalo3ZUl2VS1iX3hzdkpfbk81UzFTMVUyV1dnUlRBancxOE9IZ1UzcjhOTTVRTFg3VlJkenF2cjYyWjBIUTRMUEk2QkNfLUpnTW45UHZiRjRrM3FQNjFmdkNOWHBJNUxDR1A2dDVqcF84NGg2UzU3ZkJOTXIxSHQ0am5mQmNvTXo4NnpNRW1Fa3ZhRkJpUlhUdzVneVJpRkZFRW95Z0tYLTIya3VkcC13TTBoYkE?oc=5","date":"2022-10-25","type":"pipeline","source":"Jurist.org","summary":"Spain antitrust agency fines US pharmaceutical company 39M euros for market abuse - Jurist.org","headline":"Spain antitrust agency fines US pharmaceutical company 39M euros for market abuse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNS1lxSTZybHluWHFiNi1abThyRVV2dlFZaUpCUHcxS0s4S1lfc1J3WlAxaGtxbmQ4UlpuMGQ2S0ExTmxSZjIyREZIZWJlMkRTTTBqcmdMck5fOVhmajZhcXpES1hWUFRMUzd5ZUVsaThTSEU4WkZpN3FsQl81aHFfZ3VlRnBCMXFiczFrUmlUR3J4eUhEdlR1WUxTd0tOQTE4NDZtM1JaeEhBeTFJaWRyZEZHU3pJZw?oc=5","date":"2022-04-05","type":"pipeline","source":"Contract Pharma","summary":"Insud Pharma and Fresenius Kabi to Accelerate the Growth of mAbxience - Contract Pharma","headline":"Insud Pharma and Fresenius Kabi to Accelerate the Growth of mAbxience","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}